NCT07338851 the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Status NOT_YET_RECRUITING Phase N/A
NCT06920069 Study of Concomitant Administration of the sIPV and DTaP or MMR Status NOT_YET_RECRUITING Phase PHASE4
NCT06748612 Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) Status NOT_YET_RECRUITING Phase PHASE4
NCT06605755 Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants Status RECRUITING Phase NA
NCT06460545 Phase IV Study of Concomitant Administration of the sIPV and HepA Status NOT_YET_RECRUITING Phase PHASE4
NCT06218368 A Tool Kit to Improve Vaccine Confidence in the Philippines Status ACTIVE_NOT_RECRUITING Phase NA
NCT06162104 Evaluation of Fatigue Severity, Mood, and Quality of Life in Post-Polio Syndrome Status COMPLETED Phase N/A
NCT06114810 Immunogenicity of Novel Oral Poliovirus Vaccine Type 2 (nOPV2), bOPV and IPV Status UNKNOWN Phase PHASE4
NCT06058429 Immunogenicity of After Primary Immunization and Booster Immunization of sIPV Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05850364 A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vaccine Status COMPLETED Phase PHASE3
NCT05721274 Community Engagement and Conditional Incentives to Accelerate Polio Status COMPLETED Phase NA
NCT05684081 Effect of Digital Payment to Campaign Health Workers on Vaccination Coverage Status UNKNOWN Phase NA
NCT05083039 Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 Status COMPLETED Phase N/A
NCT04576910 Immunogenicity and Safety of the Booster Dose of Polio Vaccine With Different Primary Sequential Schedules in China Status COMPLETED Phase PHASE4
NCT04264598 Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine Status COMPLETED Phase PHASE1
NCT04264546 Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) Status COMPLETED Phase PHASE1/PHASE2
NCT04232943 Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults Status COMPLETED Phase PHASE1
NCT04177485 Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda Status COMPLETED Phase NA
NCT04027036 Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally Status COMPLETED Phase PHASE2
NCT03922061 Evaluation of Safety, Reactogenicity and Immunogenicity of Fractional-dose Inactivated Polio Vaccine (fIPV) Given Intradermally With Double Mutant Enterotoxigenic Escherichia Coli Heat Labile Toxin (dmLT) Adjuvant Status COMPLETED Phase PHASE1